Wins Diagnostics Provider of the Year for the third time, alongside Facilities and ICT accolades
Healthcare
institutions from across the region gathered in Kuala Lumpur, Malaysia, last
April 10, for the Healthcare Asia Awards 2025, which honor organizations
leading innovation and excellence in patient care. Among this year’s winners
was Singapore Diagnostics (SGD), a leading medical laboratory in the
Philippines, which earned three awards, including Diagnostics Provider of the
Year, marking its third consecutive win in the category.
SGD also received recognition for
Facilities Improvement Initiative of the Year and ICT Initiative of the Year,
underscoring its comprehensive efforts to modernize diagnostics and improve
access to quality healthcare.
SGD, the Philippine subsidiary of
Singapore-based Pathology Asia Holdings, and a provider adhering to the
stringent standards of College of American Pathologists (CAP) accreditation,
has expanded significantly since its establishment in 2013. Prior to the
pandemic, SGD served approximately 800,000 patients annually. Today, the
company operates across 60 locations and supports over two million patients a
year.
One of its key initiatives is the
groundbreaking SGD's Home Service Laboratory, offering mobile phlebotomy
services. By simply calling a local hotline, patients can schedule licensed
professionals to collect samples at their homes and deliver them to SGD labs
for processing, eliminating the need for hospital and laboratory visits, and
significantly improving convenience.
The company has also invested in
workforce development through its Credentialing Program, which provides
specialized training in hematology, immunochemistry, and microbiology. In 2024
alone, SGD’s medical technologists completed 359 training modules, equipping
its team with up-to-date technical expertise.
SGD’s award-winning ICT Initiative
includes the launch of e-SLIP (Electronic Single Laboratory Integration
Platform), which connects laboratory systems, reduces turnaround time, and
minimizes human error. Today, SGD is the send-out partner for more than 800
laboratories nationwide, thanks to its interoperability and strong digital
infrastructure.
The company also continues to explore new
technologies to improve diagnostics delivery in both urban and underserved
areas, supporting its goal of improving accessibility and patient outcomes.
Beyond its own facilities, SGD has
supported hospital transformation efforts, most notably at VisayasMed (formerly
Visayas Community Medical Center) in Cebu. Since taking over laboratory
operations in 2024, SGD has modernized the hospital’s diagnostics systems,
upgraded equipment, and retrained staff. As a result, patient cases and test
volumes grew double-digit, turn-around times for routine test results were
significantly shortened, and patient outcomes and revenue improved
significantly.
SGD is at the forefront of driving
innovation and expanding access to high-quality diagnostics in the Philippines.
Its latest accolades from the Healthcare Asia Awards reaffirm its position as a
leader, driven by a mission to make high-quality healthcare more affordable and
accessible for all Filipinos.
To know
more about SGD, visit www.singaporediagnostics.com.
No comments:
Post a Comment